Tag Archives: Multiple Sclerosis
-
-
Stopping Gilenya May Worsen Multiple Sclerosis, FDA Warns
-
Zinbryta Brain Inflammation Risks Outweigh Benefits: EMA
-
Zinbryta Risks Prevented Use As MS Drug, Despite Effectiveness of Treatment: Report
-
Zinbryta Withdrawal from U.S. Market to Be Complete April 30
-
Zinbryta Deaths, Brain Inflammation Problems Lead to Global Market Withdraw for MS Drug
-
Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths
-
Youth Concussions Increase Risk of Multiple Sclerosis: Study
-
Tysabri PML Infection Risk Increases With Long-Term Use: Study
-
Tecfidera Lawsuit Filed by Shareholder Over Biogen Ignoring Safety Signals